结直肠癌肝转移开放与微创肝切除术的前瞻性随机对照试验(LapOpHuva)
LapOpHuva随机对照试验纳入193例结直肠癌肝转移患者,比较微创肝切除(LLR,n=96)与开放肝切除(OLR,n=97),主要终点为术后并发症。LLR组总体并发症率低于OLR组(11.5% vs. 23.7%,p=0.025),严重并发症相似,长期生存结局两组相似。
要点
- LLR组总体并发症率11.5%,低于OLR组的23.7%(p=0.025)。
- 两组1、3、5、7年总生存率和无病生存率均无显著差异。
- LLR组Pringle maneuver使用更多(30.2% vs. 15.5%,p=0.025),住院时间更短(4 vs. 6天,p<0.001)。
核心结论
- 在经选择的结直肠癌肝转移患者中,LLR与OLR的肿瘤学结局相似,且LLR具有短期结果优势。
研究设计与样本
- 前瞻性随机对照试验(LapOpHuva,NCT02727179),2005年2月至2016年3月纳入204例,随机分组后193例纳入分析:LLR组96例,OLR组97例。
- 主要终点为术后并发症比较;次要终点包括肿瘤学结局、Pringle maneuver使用、手术时间、失血量、输血、住院时间、死亡率及3、5、7年总生存和无病生存。
主要发现
- LLR组总体并发症率11.5%,OLR组23.7%(p=0.025),严重并发症两组相似。
- LLR与OLR的1、3、5、7年累计总生存率分别为92.5%、71.5%、49.3%、35.6%与93.6%、69.7%、47.4%、35.5%(log-rank=0.047,p=0.82)。
- LLR与OLR的无病生存率分别为72.7%、33.5%、22.7%、20.8%与61.6%、27.2%、23.9%、17.9%(log-rank=1.427,p=0.23)。
- LLR组Pringle maneuver使用率30.2%,OLR组15.5%(p=0.025);LLR组住院时间4天,OLR组6天(p<0.001)。
- 手术时间、失血量、输血和死亡率两组无差异。
临床怎么用
- 对于经选择的结直肠癌肝转移患者,LLR可考虑作为开放手术的替代方案,短期并发症更少且住院时间更短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present surgical and oncological outcomes using a prospective and randomized trial (LapOpHuva, NCT02727179) comparing minimally invasive liver resection (LLR) versus open liver resection (OLR) in patients with colorectal liver metastases (CRLM). METHODS: Between February 2005 and March 2016, 204 selected patients with CRLM were randomized and 193 were included: LLR (n = 96) and OLR (n = 97). The primary endpoint was to compare postoperative morbidity. Other secondary endpoints were oncological outcomes, use of the Pringle maneuver, surgical time, blood losses, transfusions, hospital stay, mortality and OS, and disease-free survival (DFS) at 3, 5, and 7 years. RESULTS: LLR presented with lower global morbidity (11.5% vs. 23.7%, p = 0.025) but with similar severe complications. Long-term survival outcomes were similar in both groups. The cumulative 1-, 3-, 5-, 7-year OS for LLR and OLR were 92.5%, 71.5%, 49.3%, 35.6% versus 93.6%, 69.7%, 47.4%, 35.5%, respectively (log-rank = 0.047, p = 0.82). DFS for LLR and OLR was 72.7%, 33.5%, 22.7%, and 20.8% versus 61.6%, 27.2%, 23.9%, and 17.9%, respectively (log-rank = 1.427, p = 0.23). LLR involved more use of the Pringle maneuver (15.5% vs. 30.2%, p = 0.025) and a shorter hospital stay (4 vs. 6 days, p < 0.001). There were no differences regarding surgical time, blood losses, transfusion, and mortality. CONCLUSIONS: In selected patients with CRLM, LLR presents similar oncological outcomes with the advantages of the short-term results associated with LLR.
引用
- Robles-Campos R, Lopez-Lopez V, Brusadin R, et al. Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surg Endosc. 2019. PMID: 30701365. doi:10.1007/s00464-019-06679-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。